Read the latest news & updates….

Cognitive impairment and cerebral hypoperfusion in a CADASIL patient improved during administration of lomerizine…

Adrenomedullin for CADASIL (AMCAD)…

Correction of a CADASIL point mutation using adenine base editors in hiPSCs and blood vessel organoids…

Effect of Lomerizine Hydrochloride on Preventing Strokes in Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy…

Large NIH Grant Supports CRISPR-based Gene Therapy Development for Brain Diseases…

Download the CADASIL Awareness Brochure

Thirty Years of CADASIL Research: A Scientific Statement to Celebrate Progress and Highlight Persisting Knowledge Gaps

NOTCH3 C201R variant causes cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) that can be confused with early-onset Alzheimer’s disease

Case Report: Progressive Asymmetric Parkinsonism Secondary to CADASIL Without Dementia

Psychological difficulties in CADASIL

 CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags

CADASIL How a rare disease could help cure dementia